Key Takeaways:
- Eurofins Scientific provides a diverse range of analytical testing services to multiple industries, improving quality and safety standards.
- The biotech firm highlights the significant potential for innovation to advance food and pharmaceutical quality and safety.
- Eurofins is known for having an extensive number of validated analytical methods and an international presence.
- With continued development and investment in technology, the future of this startup as well as the industries it serves looks bright.
Based in Luxembourg, Eurofins Scientific is a biotech startup, making waves in the world of food, pharmaceutical, and environmental testing services. Since its inception in 1987, Eurofins has established an excellent reputation, becoming a global reference for comprehensive testing and support services. Over 225 laboratories scattered worldwide reflect the company’s vast reach and ambition to make food and pharmaceutical products safer and of better quality for consumers.
This startup provides unique analytical testing services, striving to achieve the highest possible quality and safety standards for products in every market. Eurofins is more than just a service provider; it’s a valuable team player that assists clients in reaching their goals and complying with regulatory authorities’ increasingly stringent demands.
What makes Eurofins stand out in the biotech industry hinges on its diverse service offer. With an impressive catalogue exceeding 130,000 validated analytical methods, Eurofins is leading the charge in food, environmental and pharmaceutical product testing. In addition, the firm supports agroscience research, genomics, discovery pharmacology, specialist clinical diagnostic testing, and serves as a pillar for clinical studies. This is a testament of Eurofins’ commitment to its clients and its continuous strive for improvement.
Furthermore, Eurofins doesn’t shy away from heavy scientific workload. It’s currently performing more than 150 million assays annually, determining the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products. Moreover, Eurofins offers innovative human diagnostic services, demonstrating its pivoting role in healthcare innovation.
Looking ahead, Eurofins foresees an exciting future of continued growth and development. Its aim to acquire and develop the most state-of-the-art analytical technologies is matched by an ambitious plan to expand its geographical presence. This paves the way for a future where the company will continue to support the ever-increasing quality and safety requirements in the markets where it operates, while answering to the growing demands from regulatory bodies and healthcare professionals.
In conclusion, the success of Eurofins Scientific and its contributions to the biotech industry signifies that innovation in biotechnology is essential for improving food and pharmaceutical quality and safety. As the company continues to expand and innovate, Eurofins is well-positioned to provide better solutions and advancements for the biotech industry. To follow their journey, check out their website or their social media platforms on Twitter, Facebook, and LinkedIn.
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
